181 related articles for article (PubMed ID: 11567884)
1. Pilocarpine treatment of xerostomia in head and neck patients.
Leek H; Albertsson M
Micron; 2002; 33(2):153-5. PubMed ID: 11567884
[TBL] [Abstract][Full Text] [Related]
2. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study.
Horiot JC; Lipinski F; Schraub S; Maulard-Durdux C; Bensadoun RJ; Ardiet JM; Bolla M; Coscas Y; Baillet F; Coche-Dequéant B; Urbajtel M; Montbarbon X; Bourdin S; Wibault M; Alfonsi M; Calais G; Desprez P; Pene F; Lapeyre M; Vinke J; Maral J
Radiother Oncol; 2000 Jun; 55(3):233-9. PubMed ID: 11041775
[TBL] [Abstract][Full Text] [Related]
3. Pilocarpine in the prevention of postirradiation xerostomia.
Lajtman Z; Krajina Z; Krpan D; Vincelj J; Borcić V; Popović-Kovacić J
Acta Med Croatica; 2000; 54(2):65-7. PubMed ID: 11028111
[TBL] [Abstract][Full Text] [Related]
4. The use of oral pilocarpine in xerostomia and Sjögren's syndrome.
Nusair S; Rubinow A
Semin Arthritis Rheum; 1999 Jun; 28(6):360-7. PubMed ID: 10406404
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of pilocarpine in postradiation xerostomia.
Greenspan D; Daniels TE
Cancer; 1987 Mar; 59(6):1123-5. PubMed ID: 3815287
[TBL] [Abstract][Full Text] [Related]
6. Systemic pilocarpine for treatment of xerostomia.
Berk L
Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1333-40. PubMed ID: 18798702
[TBL] [Abstract][Full Text] [Related]
7. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
Sangthawan D; Watthanaarpornchai S; Phungrassami T
J Med Assoc Thai; 2001 Feb; 84(2):195-203. PubMed ID: 11336078
[TBL] [Abstract][Full Text] [Related]
8. An investigation into the use of pilocarpine as a sialagogue in patients with radiation induced xerostomia.
Frydrych AM; Davies GR; Slack-Smith LM; Heywood J
Aust Dent J; 2002 Sep; 47(3):249-53. PubMed ID: 12405466
[TBL] [Abstract][Full Text] [Related]
9. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction.
Valdez IH; Wolff A; Atkinson JC; Macynski AA; Fox PC
Cancer; 1993 Mar; 71(5):1848-51. PubMed ID: 8448748
[TBL] [Abstract][Full Text] [Related]
10. Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy.
Davies AN; Thompson J
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003782. PubMed ID: 26436597
[TBL] [Abstract][Full Text] [Related]
11. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and economic evaluation of pilocarpine in treating radiation-induced xerostomia.
Taylor SE
Expert Opin Pharmacother; 2003 Sep; 4(9):1489-97. PubMed ID: 12943478
[TBL] [Abstract][Full Text] [Related]
13. Pilocarpine for radiation-induced xerostomia in head and neck cancer.
Hawthorne M; Sullivan K
Int J Palliat Nurs; 2000 May; 6(5):228-32. PubMed ID: 12419994
[TBL] [Abstract][Full Text] [Related]
14. Treatment of radiation side effects with oral pilocarpine.
Schuller DE; Stevens P; Clausen KP; Olsen J; Gahbauer R; Martin M
J Surg Oncol; 1989 Dec; 42(4):272-6. PubMed ID: 2687586
[TBL] [Abstract][Full Text] [Related]
15. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia.
Jha N; Seikaly H; Harris J; Williams D; Sultanem K; Hier M; Ghosh S; Black M; Butler J; Sutherland D; Kerr P; Barnaby P
Head Neck; 2009 Feb; 31(2):234-43. PubMed ID: 19107948
[TBL] [Abstract][Full Text] [Related]
16. Salivary scintigraphy for assessing the protective effect of pilocarpine in head and neck irradiated tumours.
Mateos JJ; Setoain X; Ferre J; Rovirosa A; Navalpotro B; Martin F; Ortega M; Lomeña F; Fuster D; Pavia J; Pons F
Nucl Med Commun; 2001 Jun; 22(6):651-6. PubMed ID: 11403176
[TBL] [Abstract][Full Text] [Related]
17. A multicenter maintenance study of oral pilocarpine tablets for radiation-induced xerostomia.
Jacobs CD; van der Pas M
Oncology (Williston Park); 1996 Mar; 10(3 Suppl):16-20. PubMed ID: 8723429
[TBL] [Abstract][Full Text] [Related]
18. Does salivary gland scintigraphy predict response to pilocarpine in patients with post-radiotherapy xerostomia?
Cooper RA; Cowan RA; Owens SE; Jeans SP; Roberts JK; Hillel PG; Slevin NJ; Allan E; Gupta NK; Collins CD
Eur J Nucl Med; 1999 Mar; 26(3):220-5. PubMed ID: 10079311
[TBL] [Abstract][Full Text] [Related]
19. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials.
Rieke JW; Hafermann MD; Johnson JT; LeVeque FG; Iwamoto R; Steiger BW; Muscoplat C; Gallagher SC
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):661-9. PubMed ID: 7852133
[TBL] [Abstract][Full Text] [Related]
20. Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia.
Wiseman LR; Faulds D
Drugs; 1995 Jan; 49(1):143-55. PubMed ID: 7705213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
